Copyright © 2022 StrategyHelix Inc. All Rights Reserved.
Global Pregnancy Test Kits Market - Outlook and Forecast 2023-2028
The global market for pregnancy test kits was valued at USD 1.70 billion in 2022 and is projected to reach USD 2.28 billion by 2028, growing at a CAGR of 5.08%. This growth can be attributed to technological advancements, new product developments, and increasing acceptance of pregnancy test kits. In recent years, there has been a significant rise in the use of digital and saliva-based pregnancy test kits, driven by a growing population of women seeking reliable and convenient testing options.
The market growth is primarily fueled by three key segments: teenage/adolescent women, maternal women, and advanced maternal-age women. These segments are increasingly aware of pregnancy and reproductive health, leading to a higher demand for pregnancy test kits. Manufacturers in the industry are focusing on research and development to meet consumer demands and offer innovative kits. The introduction of advanced technologies has resulted in more sensitive and effective pregnancy rapid tests.
|No. of Pages||
USD 1.7 billion in 2021
Sample Type, Product, Distribution Channels, and Geography
|No. of Companies Mentioned||
Digital pregnancy test kits have gained rapid adoption and are seen as the future of pregnancy testing. Products like Clearblue Easy have quickly become popular as home digital pregnancy test kits. Leading industry players are also actively developing digital pregnancy test kits. Continuous advancements in technology are expected to drive further growth in the industry.
One notable advancement is the ability of test kits to detect pregnancy up to 5 to 6 days before a missed period. These early detection kits have gained popularity, as they allow women to know their pregnancy status without having to wait for a missed period. Women who have had unprotected sex and are uncertain about their pregnancy status are among the key consumers targeted by these types of test kits.
Globally, approximately half of all pregnancies each year are unintended. Governments have recognized the need to increase knowledge about pregnancy testing as a preventive measure, especially in the context of rising unplanned pregnancies and abortion rates. Pregnancy testing kits play a crucial role in these initiatives. According to the World Family Planning 2022 report, around 41 countries have observed a significant usage of modern contraceptives among women who wish to avoid pregnancies. This population contributes to the growth of the pregnancy test kits market. Increasing awareness among adult, teenage, and maternal-age women about unintended pregnancies has led to a higher demand for pregnancy test kits as a means of family planning.
Advanced maternal-age pregnancies (age 35 and above) are known to carry certain risks for both the mother and the baby. However, such pregnancies have become increasingly common in the past two decades. Maternal risks and complications associated with advanced maternal-age pregnancies include chromosomal abnormalities, miscarriage, preterm labor, gestational diabetes mellitus, pre-eclampsia, cesarean delivery, and stillbirth. Educated women in developed countries are particularly aware of these risks and often choose to test their pregnancy status at home as a preventive measure. This trend contributes to the growth of the home pregnancy test kits market.
The market is segmented based on various factors, including sample type, product, distribution channels, and geography.
Segmentation by Sample Type
Segmentation by Product
Segmentation by Distribution Channels
Segmentation by Geography
North America – US, Canada
Europe – Germany, France, UK, Italy, Spain
Asia-Pacific – China, Japan, India, South Korea, Australia
Latin America – Brazil, Mexico, Argentina
Middle East & Africa – South Africa, Saudi Arabia, Turkey
The global market for pregnancy test kits is segmented by sample type into urine and other samples, with the urine sample segment holding a larger market share in 2022. The urine sample is widely considered as the ideal sample for pregnancy testing, commonly chosen by women and medical professionals for both clinical and home testing purposes. The high concentration of hCG hormone present in urine serves as a crucial biomarker for pregnancy, driving the growth of this segment. In at-home pregnancy tests, a positive result is typically obtained when hCG is detected in urine. Urine-based tests conducted at home generally require a higher level of hCG to yield a positive result. The ease of collection and handling, as well as the convenience of conducting tests at home, contribute to the increasing demand for urine sample-based pregnancy test kits.
In 2022, line indicator pregnancy test kits dominated the global market. These types of kits, available as over-the-counter (OTC) products, are affordable and widely accessible. As they do not require a prescription, the consumption rate of line indicators as pregnancy test kits is relatively higher compared to digital and strip types. Additionally, the availability of these kits through e-commerce platforms at affordable prices contributes to increased consumption rates.
The distribution channels for pregnancy test kits are categorized into offline and online segments. Offline channels include pharmacies, medical shops, pharmaceutical retailers, medical centers, and supermarkets, which drive higher sales and market growth. In recent years, country-level regulatory approvals and targeted distribution efforts have been instrumental in increasing access to pregnancy test kits in pharmacies. In 2022, offline distribution channels accounted for a larger share of the global market. Online channels also provide easy access and a convenient means of purchasing pregnancy test kits.
North America emerged as the dominant region in the global pregnancy test kits market in 2022, holding a share of approximately 33%. Factors such as high awareness and acceptance of pregnancy testing among teenagers, increased expenditure on reproductive healthcare by adult and advanced maternal-age women, and the growing burden of unintended pregnancies in the region contribute to market growth.
The Asia-Pacific (APAC) region is experiencing rapid growth in the pregnancy test kits market and is expected to witness the highest growth rate during the forecast period. The region’s strong potential and targeted population drive significant demand for pregnancy test kits. Growing awareness about these technologies and advanced pregnancy test kits, along with the presence of local and global market players engaging in promotional activities, contribute to the adoption rate of pregnancy test kits in APAC.
The global market for pregnancy test kits is characterized by intense competition, with numerous global, regional, and domestic players offering a wide range of pregnancy test kits. Certain global industry players have achieved significant market penetration through extensive distribution networks and effective business strategies. Furthermore, some companies engage in collaborations with healthcare institutions and government authorities to boost the sales of pregnancy test kits. The competitive landscape varies across different countries. In North America, the competition in the pregnancy test kits market is particularly fierce due to high consumer spending, robust offline and online distribution channels, and a high adoption rate of pregnancy test kits.
Abbott, Church & Dwight, and SPD Swiss Precision Diagnostics GmbH are among the prominent players in the global pregnancy test kits market. Swiss Precision Diagnostics holds a leading position in the market, reaching approximately 30 million women annually to promote the sale of their pregnancy test kits. The company emphasizes the development of various pregnancy test kit models and structures that provide convenience for women.
Key companies profiled in this report include Abbott, Church & Dwight, SPD Swiss Precision Diagnostics GmbH, AccuBioTech, Axis Medicare, AdvaCare Pharma, Biosynex, bioMérieux, Cardinal Health, Cupid Limited, Confirm BioSciences, Cyclotes.de, Everly Health (Natalist), Fairhaven Health, Femometer, Geratherm Medical AG, Germaine Laboratories, INTEC, Johnson & Johnson, Mankind Pharma, Meril Life Sciences, MP Biomedicals, Medsource Ozone Biomedicals, Healthpoint, Princeton BioMeditech Corporation, Piramal Enterprises Ltd (Piramal Pharma), QuidelOrtho, Ro, Salignostics, Siemens Healthineers, SUGENTECH, Türklab A.S., Trinity Biotech, Wondfo.
Key Questions Answered
What is the current valuation of the pregnancy test kits market?
As of 2022, the pregnancy test kits market was valued at USD 1.70 billion.
What is the projected valuation of the pregnancy test kits market by 2028?
By 2028, the pregnancy test kits market is expected to reach a valuation of USD 2.28 billion.
What is the compound annual growth rate (CAGR) of the pregnancy test kits market?
The pregnancy test kits market is experiencing a CAGR of 5.08% from 2022 to 2028.
Who are the major players in the global pregnancy test kits market?
The key players in the global pregnancy test kits market include Abbott, Church & Dwight, and SPD Swiss Precision Diagnostics GmbH.
What are the notable trends in the pregnancy test kits market?
The industry is witnessing several notable trends, including the emergence of digital pregnancy testing kits, advancements in early pregnancy detection technology, and the development and introduction of next-generation pregnancy test kits.
Which region dominates the global pregnancy test kits market in terms of market share?
North America holds the largest market share in the global pregnancy test kits market, accounting for 33% of the total market share.